We demonstrate a significant association between longer CAG repeats in the hKCa3/KCNN3 calcium-activated potassium channel gene and schizophrenia in Israeli Ashkenazi Jews. We genotyped alleles from 84 Israeli Jewish patients with schizophrenia and from 102 matched controls. The overall allele frequency distribution is significantly different in patients vs controls (P = 0.00017, Wilcoxon Rank Sum test), with patients showing greater lengths of the CAG repeat. Northern blots reveal substantial levels of ෂ9 kb and ෂ13 kb hKCa3/KCNN3 transcripts in brain, striated muscle, spleen and lymph nodes. Within the brain, hKCa3/KCNN3 transcripts are most abundantly expressed in the substantia nigra, lesser amounts are detected in the basal ganglia, amygdala, hippocampus and subthalamic nuclei, while little is seen in the cerebral cortex, cerebellum and thalamus. In situ hybridization reveals abundant hKCa3/KCNN3 message localized within the substantia nigra and ventral tegmental area, and along the distributions of dopaminergic neurons from these regions into the nigrostriatal and mesolimbic pathways. FISH analysis shows that hKCa3/KCNN3 is located on chromosome 1q21.
Introduction
Schizophrenia is a chronic disabling disorder with a lifetime morbid risk of 1% in the general population. The illness has a significant genetic component 1 and often develops in early adulthood. Although still controversial, 'anticipation' (an increase in severity through successive generations) has been reported in studies of affected families. 2 Trinucleotide repeat expansions have been found to underlie several Mendelian hereditary neurological diseases 3, 4 and intergenerational lengthening of such repeats are thought to underlie the phenomenon of 'anticipation'. In the past few years, expanded 'anonymous' CAG repeats in unidentified genes have been reported in patients with schizophrenia, with considerable overlap between Correspondence: Dr R Navon, Department of Molecular Genetics, Sapir Medical Center, Kfar Sava 44281, Israel. E-mail: navonȰ post.tau.ac.il * VD and ES contributed equally to this work Received 14 August 1998; revised and accepted 5 November 1998 allele distributions in patients and controls; 5 this has been taken as further suggestive evidence that genes containing trinucleotide repeats may play a role in neuropsychiatric disorders.
The human KCa3 (hKCa3/KCCN3) gene, encoding one member of a recently described family of calciumactivated potassium channels, 6 contains two adjacent polyglutamine repeat arrays separated by an SH3-association domain (PXXP 6 ) 7 in its N-terminal region; 8 these features have subsequently been recognized to be present in the rat gene as well (GenBank accession numbers AF031815, U69884). The second polyglutamine repeat is highly polymorphic in Caucasian European and North American populations, ranging from 10-28 repeats in length, with a modal value of 19 repeats. 8, 9 Case-control studies have recently shown a significant over-representation of longer hKCa3/KCNN3 CAG-repeat alleles in Caucasian schizophrenia patients compared with ethnically matched controls, although there is considerable overlap in allele sizes, and the modal allele has 19 repeats for all these populations. 8, 9 hKCa3/KCNN3 potassium channel gene V Dror et al
In this report we firstly confirm the previously described association between the presence of longer CAG repeats in the hKCa3/KCNN3 gene and schizophrenia in Israeli Ashkenazi Jews. Second, we reveal the presence of hKCa3/KCNN3 transcripts in specific regions of the human brain that have previously been implicated in schizophrenia, using Northern blot analyses and in situ hybridization. Third, we localize the hKCa3/KCNN3 gene to chromosome 1q21 by fluorescence in situ hybridization (FISH).
Materials and methods

Subjects
This study was performed after approval by the Israeli Ethics Committee, and all subjects provided informed consent permitting use of their DNA for research. Eighty-four Ashkenazi Jewish patients with schizophrenia, ages 12-71, meeting DMS-IV criteria for schizophrenia 10 were recruited among patients hospitalized in Abarbanel Mental Health Center, Bat-Yam, Israel. Diagnoses were made during hospitalization by semistructured interviews based on the Hebrew version of the Structured Clinical Interview for DSM-III R, 11 and confirmed by a consensus of at least two board certified psychiatrists (ES, RK, MS, YB). Diagnoses were established prior to the genetic study, and patients were not included if there was any disagreement in diagnosis. Israeli controls were recruited from our 'DNA bank' established from whole blood from healthy individuals between 25-40 years of age who agreed to provide their DNA for research. We selected 102 Ashkenazi Jewish individuals who did not report any known history of psychiatric disease in their families.
Statistical analysis
The Wilcoxon Rank sum test with tied midranks 12 was used to compare pairs of frequency distributions. For comparison of multiple distributions the KruskalWallis test 12 was used. Testing for correlation was done by the t-test. 13 Computer programs to carry out these tests were kindly provided by Dr Howard Tucker (Department of Mathematics, University of California, Irvine, CA, USA). Neither the control nor the patient population showed a significant deviation from expected Hardy-Weinberg genotype frequencies (P = 0.27-0.29) by the Genetic Data Analysis program. 14 
Allele sizing
Genomic DNA was prepared from 10 ml of peripheral blood, 15 and amplified by PCR using the following primers: forward: 5Ј GCAGCCCCTGGGACCCTCGCT 3Ј; reverse: 5Ј ACATGTAGCTGTGGAACTTGGAGAGT 3Ј.
The expected product size is about 300 bp, and depends on the number of CAG repeats in the polymorphic cluster in the N-terminal region of hKCa3/KCNN3. PCR was performed in a final volume of 15 l with ␣ 32 P dCTP and 10% dimethyl sulfoxide in the reaction mixture. PCR conditions were as follows: 94°C for 3 min; 30 cycles of 94°C for 30 s, 65°C for 30 s, 72°C for 45 s, and 72°C for 7 min. The PCR products were diluted in formamide loading buffer, denatured at 70°C for 10 min and loaded onto a denaturing sequencing gel. The PCR product sizes were determined by comparison with an M13 sequencing ladder and to three sequenced clones with known CAG repeat length. 8 The trinucleotide repeats often do not appear as single discrete DNA bands on polyacrylamide gel, but rather as one major band accompanied by one or more 'stutter' bands owing to PCR artifacts; in such cases the strongest band for each allelic form was used for the determination. The presence of a single band was scored as a homozygous allele. All genotyping was performed in Israel, and was carried out in a blinded fashion with control and patient samples randomly mixed together. The number of CAG repeats of several DNA samples was independently confirmed at Irvine. 8 
Northern blot and in situ hybridization analysis
Northern blots of RNA from human tissues (multiple organs, lymphoid tissues, and various regions of brain) were obtained from Clontech (Palo Alto, CA, USA). An hKCa3-specific ෂ500-bp ApaI fragment (nucleotides 330-825 in the coding region) that does not hybridize with any other related KCa/KCNN gene was used to probe these blots at a final stringency of 0.1 × SSC, 0.1% SDS for 30-40 min at 55°C. All blots were exposed at −80°C with an intensifying screen for 15 days.
Blocks for histological studies of the upper brainstem and basal ganglia were cut from fresh-frozen coronal slabs of the brains of two normal adults with no history of drug abuse or neurological illness and no evident Alzheimer's pathology. 16 For in situ hybridization, the temperature of each block was raised to 4°C over 20 min. Blocks were then fixed in cold 4% paraformaldehyde in 0.1 M phosphate buffer for ෂ24 h at 4°C, infiltrated with 30% sucrose, re-frozen in dry ice, and finally sectioned serially in the frontal plane on a freezing microtome at 40 m. Free-floating sections were hybridized with 1 × 10 6 cpm l −1 of [␣-33 P-UTP]-labeled, anti-sense (or sense) riboprobes transcribed from a linearized cDNA template, using a previously described protocol. 17 cRNA probe concentration and specific activity were approximately the same in all in situ runs. Sense controls gave weak background labeling only, comparable to that seen over the white matter. After hybridization, the sections were exposed to ␤-Max autoradiographic film (Amersham, Arlington Heights, IL, USA) for 10-14 days. After film development, slides were dipped in Kodak NTB2 photographic emulsion, exposed at 4°C for 6 weeks, developed in Kodak D19 developer, fixed with Kodak Rapid Fix and counter-stained with cresyl violet.
Chromosomal localization
Determination of chromosomal localization was carried out by FISH using an hKCa3/KCNN3-specific genomic probe. Genomic clones were isolated by screening an EMBL3 human genomic library with radiolabeled probe produced by PCR from various regions of the hKCa3/KCNN3 cDNA. Genomic clones were restriction-mapped and partially sequenced. An exon/intron boundary was defined when the genomic sequence diverged from that of the cDNA and a consensus splice donor site was recognized. The hKCa3/KCNN3-specific probe used for FISH consisted of a BlueScript vector bearing an ෂ8 kb XbaI fragment which included the ෂ1.2 kb exon I, ෂ3 kb of intron sequence, and ෂ3.7 kb of sequence 5Ј to exon I.
Metaphase spreads were prepared from human peripheral blood lymphocytes stimulated with phytohemagglutinin and cultured as described previously. 18 The probe was labeled using a digoxigenin-labeling kit (Boehringer-Mannheim, Indianapolis, IN, USA), according to the protocol recommended by the manufacturer. In situ hybridization and signal detection were carried out essentially according to the one-color FISH protocol described by Litmanovitch et al. 18 Signals were visualized on an Olympus BH2 fluorescence microscope fitted with a triple band-pass filter (Chroma Technology, Brattleboro, VT, USA). Forty metaphase cells were analyzed.
Results
Association between length of CAG repeats in hKCa3/KCNN3 and schizophrenia in Israeli Ashkenazi Jews
The number of CAG repeats in the second CAG region of the hKCa3/KCNN3 gene was analyzed in 84 Israeli Ashkenazi patients with schizophrenia and in 102 unaffected Ashkenazi controls. Figure 1 shows the frequency of alleles with different CAG repeat lengths for all patients with schizophrenia and unaffected controls. This repeat is highly polymorphic in both popu- lations, with an overall range of alleles from 4 to 24 CAGs. The modal repeat length for both patient and control groups is 19 CAG repeats, as reported in European and North American Caucasians. 8, 9 A slight bimodal character is evident in these distributions, with a smaller peak present at 12-14 repeats, as has also been reported in two previous studies. 8, 9 The two longest alleles (23 and 24 repeats) are uniquely represented among patients. Using the Wilcoxon Rank Sum test we find that the distributions of alleles are significantly different between patients and controls (P = 0.00017). The difference between patients and controls in this Ashkenazi Jewish population is statistically more robust than those found in earlier studies on European and North American Caucasian populations. 8, 9 We found no significant relationship between length of CAG repeats and the severity of disease as measured by the total number of recorded hospitalizations (P = 0.94, Kruskal-Wallis). We did find a very weak, but statistically significant positive correlation (r = 0.19, P = 0.007) between CAG repeat length and greater age at first hospitalization, a measure of the ageof-onset of disease. The significance of this association is not clear, although a similar relationship has been reported by Bowen et al. 9 
Expression of hKCa3/KCNN3 transcripts in human tissues
Our findings further confirm an association between the length of the CAG repeat in hKCa3/KCNN3 and schizophrenia in Israeli Ashkenazi Jews. While we have speculated on the mechanisms by which CAG repeats in hKCa3/KCNN3 might affect the risk of developing schizophrenia, 8, 19 any understanding of such processes clearly requires knowledge of where this gene is expressed within human tissues, and how its distribution might relate to disease symptoms. We therefore undertook Northern blot and in situ hybridization studies, probing diverse human tissues with an hKCa3/KCNN3-specific DNA fragment.
Among a variety of human tissues examined, Northern blot analysis revealed hKCa3/KCNN3-specific expression to be largely limited to brain, striated muscle and lymphoid tissues (Figure 2, panels a and b) . Some smaller mRNA species were also visible, for example in skeletal muscle and some lymphoid tissues. The expression of hKCa3/KCNN3 in lymphoid tissue is consistent with the isolation from human lymphocytes of several expressed sequence tags (ESTs) representing this gene (accession numbers AA491238, Y08263, AA285078, AA284005). This pattern is largely consistent with results reported from studies in the rat. 6 It should also be noted that the multiplicity of transcripts seen in our Northern blots is not unusual for potassium channel genes (reviewed in 20 ) . Within the brain, a relatively high intensity of hKCa3/KCNN3 mRNA was detected in the human substantia nigra, basal ganglia, and subthalamic nuclei (Figure 2, panels c and d) . The human hippocampus and amygdala, two regions which have been implicated in affect and psychosis, 21 ,22 also show abundant expression of hKCa3/KCNN3. Lower levels of hKCa3/KCNN3 expression are seen in the cerebral cortex, cerebellum and thalamus. Consistent with these findings, in situ hybridization studies on sections of human midbrain (Figure 3 ) more precisely localize hKCa3/KCNN3 transcripts within the human substantia nigra (panel a) and ventral tegmental area (panel b). hKCa3/KCNN3 mRNA was also found in the putamen (panel c), but not in the red nucleus, cerebral peduncle or globus pallidus. Figure 4 shows a schematic representation of the genomic organization of hKCa3/KCNN3 surrounding the XbaI fragment which was used as a probe for FISH analysis. Following hybridization with the probe, clear signals were detected on the long arm of chromosome 1 (1q21), at the distal edge of the heterochromatic block which appears as a bright blue spot following DAPI counterstaining (panel c). Seventy five percent (30 out of 40) of the analyzed cells revealed clear hybridization signals on both homologues of chromosome 1. Thus, hKCa3/KCNN3 appears to be located on chromosome 1q21, despite the sequence-tagged site STS G16005 (which contains ෂ600 nucleotides of hKCa3 sequence) being reported in the CHLC database as being localized to chromosome 22q11.
Localization of hKCa3/KCNN3 to chromosome 1q21
Discussion
In this study we find a significant difference in the CAG repeat length in the hKCa3/KCNN3 gene between Israeli Ashkenazi Jewish patients with schizophrenia and ethnically matched controls. The magnitude and statistical significance of these differences is greater than those obtained in previously reported studies on Caucasian populations from France, the United Kingdom, Ireland and North America, 8, 9 which may be the result of a higher degree of genetic homogeneity within this Ashkenazi population. 23 Expanded CAG alleles are generally dominant in those neurodegenerative diseases in which they have been implicated, and the phenotype they produce is qualitatively different from that of null alleles; the pathogenicity of such expanded polyglutamine repeats is therefore thought to be the result of a 'gain-of-function'. 24 If longer polyglutamine repeats in hKCa3/KCNN3 enhance channel function in some graded manner, one might expect the membrane potential of neurons expressing these channels to become excessively hyperpolarized, leading to a progressive lengthening in the inter-spike interval and an alteration of neuronal excitability.
The number of glutamines in the polymorphic region we have studied (generally containing between 10 and 24 repeats) is smaller than those characterizing the disease-associated alleles in other CAG-repeat diseases (eg Huntington's), 24 and smaller than the threshhold of 35-40 repeats hypothesized by Perutz et al 25 to be required for a polyglutamine-induced transition to an abnormal oligomerized state. However, it should be kept in mind that biochemical, biophysical and direct structural data all indicate that functional potassium channels exist as tetramers, with their N-and C-termini located within the cytoplasm. 20 Thus, there might exist interactions between the polymorphic as well as nonpolymorphic polyglutamine regions of different subunits, together creating a domain with properties similar to the much larger polyglutamine expansions found in the classical CAG diseases. It is also of note that SCA6, a dominant CAG repeat disease caused by small expansions in a calcium channel gene, has pathogenic alleles of the same size seen in hKCa3/KCNN3. 26 Knowledge of the tissue distribution of hKCa3/KCNN3 will clearly be important to develop an understanding of the role of this gene in affecting disease risk. Combining the information from our Northern blots and in situ hybridization studies, we see localized expression of hKCa3/KCNN3 within the human substantia nigra, ventral tegmental area, basal ganglia, subthalamic nuclei, amygdala and hippocampus ( Figure 3 ). This distribution is consistent with hKCa3/KCNN3 being expressed in dopaminergic neurons of the nigrostriatal and mesolimbic pathways, two of the four major dopaminergic pathways in human brain. These two pathways also encompass the very limited region of the CNS that expresses dopamine D 2 receptors, and the clinical potency of antipsychotic drugs appears to correlate with their affinity for this specific isoform of the dopamine receptor. 27 Additionally, imaging and functional studies have previously implicated these two pathways in the pathogenesis of schizophrenia. 28 More detailed in situ hybridization studies will be required to refine the location of hKCa3-expressing cells and clarify their relationship to these dopaminergic pathways.
Concluding remarks
Expansion of polyglutamine repeats in many proteins is known to cause neurodegenerative disorders. However, since the normal physiological function of most of these proteins is largely unknown, the molecular mechanisms by which expanded repeats cause disease remain elusive. In contrast, the hKCa3 channel with its polymorphic polyglutamine repeats provides a model system to study the effect of polyglutamine expansions on protein function and disease pathogenesis, since its physiological functions are known, and single molecular events can be resolved at sub-millisecond resolution. 19 In this study, we confirm an association between polyglutamine repeat length in hKCa3/KCNN3 and schizophrenia in Israeli Ashkenazi Jews. The hKCa3/KCNN3 gene is expressed in restricted regions of the brain which have been suggested to be implicated in schizophrenia. Future functional studies on hKCa3 proteins with short and long polyglutamine repeats will be required to clarify the pathogenic mechanisms underlying hKCa3's role in schizophrenia, as well as to shed light on the mechanisms underlying other trinucleotide expansion diseases.
Note added in proof
The chromosomal location of hSKCa3 we report here is consistent with that recently reported by Wittekindt et al, Neurogenetics 1998; 1: 259-265. The same localization was found by Antonarakis et al, personal communication to GA Gutman to be published in Am J Med Genetics, 1999.
